SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.